Danny Matthews
Health Technology
Profile
Danny Matthews worked as a Director of Investor Relations and Communications at BELLUS Health, Inc.
Former positions of Danny Matthews
| Companies | Position | End |
|---|---|---|
| BELLUS HEALTH | Investor Relations Contact | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Danny Matthews
